International Clinical Trial: Prospective study of the efficacy, durability, and imaging biomarkers of Aflibercept 8 mg using a personalized treat-and-extend regimen in diabetic macular edema : A 48-Week Prospective Study

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (KCT0012571) titled 'Prospective study of the efficacy, durability, and imaging biomarkers of Aflibercept 8 mg using a personalized treat-and-extend regimen in diabetic macular edema : A 48-Week Prospective Study' on Sept. 7.

Study Type: Interventional Study

Study Design: Primary Purpose : Treatment, Intervention Model : Single Group, Blinding/Masking : Open, Allocation : Not Applicable

Primary Sponsor: KyungHee University Medical Center

Condition:

Diseases of the eye and adnexa

Intervention: Drug : Product Name: EYLEA(R) Prefilled Syringe 8mg

Active Ingredient: Aflibercept

Dose: 8 mg

Route of Administration: Intravitreal injec...